Single-agent lenalidomide for newly diagnosed myeloma with on-demand dexamethasone: A phase II trial.
F. Buadi
No relevant relationships to disclose
M. Lacy
Research Funding - Celgene
A. Dispenzieri
Honoraria - Binding Site
Research Funding - Celgene
B. LaPlant
No relevant relationships to disclose
K. M. Laumann
No relevant relationships to disclose
G. S. Nowakowski
No relevant relationships to disclose
S. R. Hayman
No relevant relationships to disclose
K. Detweiler Short
No relevant relationships to disclose
D. Dingli
No relevant relationships to disclose
M. A. Gertz
Honoraria - Celgene; Millennium
P. R. Greipp
No relevant relationships to disclose
J. A. Lust
No relevant relationships to disclose
T. E. Witzig
No relevant relationships to disclose
S. R. Zeldenrust
No relevant relationships to disclose
S. J. Russell
No relevant relationships to disclose
V. Rajkumar
No relevant relationships to disclose
S. Kumar
Consultant or Advisory Role - Merck
Research Funding - Celgene; Cephalon; Genzyme; Millennium; Novartis